Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. M3 Wake Research - Charleston
Claim This Site
Are you the site administrator? Claim this site to update information.
Source: Trial-derived.
5Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
7Unique Conditions
Source: Trial-derived.
5Unique Sponsors
Affiliations
Associated Organizations
Conditions
Source: Trial-derived. Diabetic Peripheral Neuropathic Pain (2)Source: Trial-derived. Atherosclerotic Cardiovascular Disease (ASCVD) (1)Source: Trial-derived. Elevated Lp(a) (1)Source: Trial-derived. Influenza, Human (1)Source: Trial-derived. Obesity (1)Source: Trial-derived. Overweight (1)Source: Trial-derived. Type 2 Diabetes (1)
Sponsors
Source: Trial-derived. Vertex Pharmaceuticals Incorporated (2)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. Parexel (1)Source: Trial-derived. Seqirus (1)Source: Trial-derived. Zealand Pharma (1)
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Additional Capabilities
Other capabilities inferred from trial participation
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay